Business Context and Reporting Period
Company: Corpay, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 23, 2025
Event: Entry into a Material Definitive Agreement to acquire Alpha Group International plc ("Alpha").
Key Financial Metrics and Transaction Terms
- Offer Price: £42.50 per share in cash.
- Implied Enterprise Value: Approximately £1.6 billion.
- Financing: Corpay secured a £1.875 billion bridge term loan facility from BOFA Securities, Inc., Barclays Bank PLC, and JPMorgan Chase Bank, N.A.
- Shareholder Support: Irrevocable undertakings received for approximately 13.83% of Alpha's outstanding shares (5,849,180 shares).
Material Changes and Transaction Structure
Corpay announced a firm intention to acquire all issued and to be issued ordinary share capital of Alpha via a court-sanctioned scheme of arrangement under Part 26 of the United Kingdom Companies Act 2006. The transaction is subject to a Co-operation Agreement entered into on July 23, 2025.
- Completion Conditions: Requires approval by Alpha shareholders (majority in number representing 75% in value), Court sanction, and customary regulatory approvals.
- Expected Closing: Fourth quarter of 2025, subject to conditions.
- Long Stop Date: May 23, 2026 (11:59 pm London time), unless extended by mutual agreement and Panel consent.
Guidance, Risks, and Contingencies
The filing does not provide updated financial guidance or outlook for Corpay's existing operations. The transaction is contingent on several risks and conditions:
- Termination Risks: The agreement may be terminated if the acquisition does not complete by the Long Stop Date, if Alpha directors withdraw their recommendation, if a competing proposal emerges, or if shareholder/Court approval is not obtained.
- Financing Conditions: The bridge facility is subject to customary conditions precedent.
- Regulatory Approval: Completion is conditioned on receiving necessary regulatory approvals.
Investor Verification Checklist
- Verify the final approval status of the Scheme by Alpha shareholders and the UK Court.
- Monitor the status of regulatory approvals required for the cross-border acquisition.
- Confirm the drawdown of the £1.875 billion bridge facility and any refinancing plans.
- Review the full text of the Rule 2.7 Announcement (Exhibit 2.1) and Co-operation Agreement (Exhibit 10.1) for specific termination rights and covenants.
- Assess the impact of the £1.6 billion enterprise value on Corpay's future leverage ratios and liquidity position.